Cargando…

Positive Response to Thermobalancing Therapy Enabled by Therapeutic Device in Men with Non-Malignant Prostate Diseases: BPH and Chronic Prostatitis

Background: The most common types of non-malignant prostate diseases are benign prostatic hyperplasia (BPH) and chronic prostatitis (CP). The aim of this study was to find out whether thermobalancing therapy with a physiotherapeutic device is effective for BPH and CP. Methods: During a 2.5-year peri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aghajanyan, Ivan Gerasimovich, Allen, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5456275/ https://www.ncbi.nlm.nih.gov/pubmed/28933398 http://dx.doi.org/10.3390/diseases4020018

Ejemplares similares

The Vascular Factor Plays the Main Role in the Cause of Pain in Men with Chronic Prostatitis and Chronic Pelvic Pain Syndrome: The Results of Clinical Trial on Thermobalancing Therapy
por: Allen, Simon
Publicado: (2017)

BPH and prostate cancer risk
por: Miah, Saiful, et al.
Publicado: (2014)

Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
por: Kucukdurmaz, Faruk, et al.
Publicado: (2017)

Androgen Regulated Genes in Human Prostate Xenografts in Mice: Relation to BPH and Prostate Cancer
por: Love, Harold D., et al.
Publicado: (2009)

Inflammasomes are important mediators of prostatic inflammation associated with BPH
por: Kashyap, Mahendra, et al.
Publicado: (2015)

Development of Interpretable Predictive Models for BPH and Prostate Cancer
por: Bermejo, Pablo, et al.
Publicado: (2015)

Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
por: Sciacqua, L. V., et al.
Publicado: (2023)

Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil
por: Park, Hyun Jun, et al.
Publicado: (2013)

The Role of TURP in the Detection of Prostate Cancer in BPH Patients with Previously Negative Prostate Biopsy
por: Kim, Dae Keun, et al.
Publicado: (2010)

Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH
por: Saito, Motoaki, et al.
Publicado: (2014)

Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
por: Kang, JiHun
Publicado: (2021)

Real‐world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain
por: María Molero, José, et al.
Publicado: (2020)

Detection of Prostatic Inflammation From Peripheral Lymphocyte Count and Free/Total PSA Ratio in Men With LUTS/BPH
por: Liao, Xinyang, et al.
Publicado: (2020)

Recent advances in prostate cancer and BPH : the proceedings of the IV Congress on Progress and Controversies in Oncological Urology (PACIOU IV), held in Rotterdam, the Netherlands, April 1996 /
Publicado: (1997)

Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events
por: Ko, Young Hwii, et al.
Publicado: (2010)

Therapeutic potential of pomegranate juice-derived nanovesicles in nude mouse benign prostatic hyperplasia (BPH) xenograft model
por: Sreekumar, Amritha, et al.
Publicado: (2023)

Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?
por: Kaplan, Steven A, et al.
Publicado: (2011)

Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)
por: Cambio, Angelo J, et al.
Publicado: (2007)

Characterizing Prostiva(TM) RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI
por: Huidobro, Christian, et al.
Publicado: (2009)

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?
por: Foo, Keong Tatt
Publicado: (2019)

1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)
por: Patel, Nikisha, et al.
Publicado: (2021)

Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH.
por: Brawn, P. N., et al.
Publicado: (1994)

The Prostate Cancer Patient Had Higher C-Reactive Protein Than BPH Patient
por: Kim, Youngjun, et al.
Publicado: (2013)

L.I.F.T. study: Prostatic urethral lift for the treatment of LUTS associated with BPH
por: Gupta, Saurabh
Publicado: (2014)

How Readable Is BPH Treatment Information on the Internet? Assessing Barriers to Literacy in Prostate Health
por: Koo, Kevin, et al.
Publicado: (2016)

Early Experience with Laparoscopic Retropubic Simple Prostatectomy in Patients with Voluminous Benign Prostatic Hyperplasia (BPH)
por: Yun, Han Ki, et al.
Publicado: (2010)

Assessing the Influence of Benign Prostatic Hyperplasia (BPH) on Erectile Dysfunction (ED) among patients in Poland
por: Dutkiewicz, Sławomir, et al.
Publicado: (2012)

Endogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients
por: Asare, George Awuku, et al.
Publicado: (2017)

Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network
por: Hellwege, Jacklyn N., et al.
Publicado: (2019)

Evaluation of the Antioxidant and Antiangiogenic Activity of a Pomegranate Extract in BPH-1 Prostate Epithelial Cells
por: Consoli, Valeria, et al.
Publicado: (2023)

Management of BPH then 2000 and now 2016 – From BPH to BPO
por: Braeckman, Johan, et al.
Publicado: (2017)

miRNA-21 Serum Evaluation in BPH, Hormone Sensitive Prostate Cancer, and Castrate Resistant Prostate Cancer: Attempt for Diagnostic Biomarker Evaluation
por: Seputra, Kurnia Penta, et al.
Publicado: (2021)

Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract
por: Asare, George Awuku, et al.
Publicado: (2015)

Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome
por: Stewart, Kendal L., et al.
Publicado: (2023)

Molecular Breeding of Rice Restorer Lines and Hybrids for Brown Planthopper (BPH) Resistance Using the Bph14 and Bph15 Genes
por: Wang, Hongbo, et al.
Publicado: (2016)

Risk of Prostate Cancer after Trans Urethral Resection of BPH: A Cohort and Nested Case-Control Study
por: Karlsson, Camilla T., et al.
Publicado: (2011)

Prostate epithelial stem cells are resistant to apoptosis after α1-antagonist treatment. The impact for BPH patients
por: Bajek, Anna, et al.
Publicado: (2011)

Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis
por: Kim, Sang-Su, et al.
Publicado: (2016)

Erratum to “Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract”
por: Evidence-Based Complementary and Alternative Medicine,
Publicado: (2019)

Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH)
por: Saponaro, Miriam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1lluakgfifehb48s0bns2ioqjb